Related Experiment Videos
Granulocytic sarcoma of the temporal bone.
B Lee1, G M Fatterpekar, William Kim
1Department of Otolaryngology, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029, USA.
AJNR. American Journal of Neuroradiology
|October 10, 2002
Summary
Granulocytic sarcoma, a rare tumor, can affect the temporal bone and often indicates leukemia. Early chemotherapy can lead to tumor regression and improved survival in these cases.
Area of Science:
- Oncology
- Hematology
- Neurology
Background:
- Granulocytic sarcoma is an extramedullary tumor composed of immature granulocytes.
- It is frequently associated with acute myelogenous leukemia (AML) or chronic myelogenous leukemia (CML).
- Temporal bone involvement is an uncommon presentation.
Observation:
- A case of granulocytic sarcoma involving the temporal bone is presented.
- The tumor's location in the temporal bone is unusual.
- The patient's clinical presentation and diagnostic findings are detailed.
Findings:
- The granulocytic sarcoma was diagnosed in the temporal bone.
- This finding suggested an underlying myeloproliferative neoplasm.
- The tumor responded well to aggressive chemotherapy.
Implications:
- Early recognition of granulocytic sarcoma, even in rare locations like the temporal bone, is crucial.
- Prompt and aggressive chemotherapy can induce tumor regression.
- Timely intervention may improve patient prognosis and longevity in cases of leukemia.